Gayatri BioOrganics Ltd (GAYATRIBI) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Gayatri BioOrganics Ltd on NSE and BSE, with an AI summary of each filing.
Gayatri Bioorganics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve 1.Un-audited Financial ....
Intimation · 05 Nov 2026, 5:30 am
Ananth BioOrganics Schedules Board Meeting to Approve Q2 Results Ananth BioOrganics Limited (formerly Gayatri BioOrganics Limited) has scheduled a Board of Directors meeting on 5th Nov'26 at its registered office. The board will primarily consider and approve the un-audited financial results alongside the Limited Review Report for the quarter and half-year ended 30th Sep'26, in addition to addressing other routine business matters.
Scrutinizer''s Report for the 35th AGM held on 23.09.2026
Annual General Meeting · 23 Sept 2026, 11:42 pm
Outcome of 35th Annual General Meeting held on 23.09.2026
Annual General Meeting · 23 Sept 2026, 11:40 pm
Notice of AGM for the FY 2025-26 scheduled to be held on 23.09.2026
Annual General Meeting · 01 Sept 2026, 10:55 pm
Annual Report for the FY 2025-26 of the Company.
Others (Uncategorized) · 01 Sept 2026, 10:42 pm
Change in Management
Change in Management · 04 Aug 2026, 11:49 pm
Gayatri BioOrganics Announces Leadership and Name Change Amid Q1FY27 Loss Gayatri BioOrganics reported a net loss of ₹10.17 lakhs for Q1FY27 ended 30 Jun'26, compared to a loss of ₹26.29 lakhs YoY and a loss of ₹42.05 lakhs QoQ. The Board approved a company name change to Ananth BioOrganics or a similar name, pending approvals. Chairman Venkata Sandeep Kumar Reddy Tikkavarapu resigned effective 05 Aug'26, and Whole-time Director Sreedhara Reddy Kanaparthi was elevated to Chairman and Managing Director. The 35th AGM is scheduled for 23 Sep'26.
Unaudited Finacial Results along with Limited Review Report for the quarter ended 30.06.2026
Financial Result · 04 Aug 2026, 11:35 pm
Gayatri BioOrganics Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 234 ■ EBITDA: 0.5 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 0.2 ■ PAT: -10.2 (+61.3% YoY | +75.8% QoQ) ■ EPS (INR): -0.01 (+66.7% YoY | +80.0% QoQ)
Gayatri Bioorganics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve 1. Un-audited Financial ....
Intimation · 04 Aug 2026, 5:30 am
Gayatri BioOrganics Sets Board Meeting for Q1 FY27 Results Gayatri BioOrganics Limited (BSE: 524564) has scheduled a Board of Directors meeting on 04 Aug'26. The primary agenda is to consider and approve the un-audited financial results for the quarter ended 30 Jun'26. The company also announced that the trading window for insiders has been closed from 01 Jul'26 and will remain so until 48 hours after the financial results are declared, in compliance with SEBI insider trading regulations.
Submission of Revised Audited Financial Results for the Quarter and Year Ended 31.03.2026 due to typographical error for Board Meeting held on 19.05.2026
Others (Uncategorized) · 20 May 2026, 12:55 am
Gayatri Bioorganics Revises FY26 Results; Cites Typographical Errors Gayatri Bioorganics submitted revised audited financial results for Q4 and FY ended 31 Mar'26, citing typographical errors in the prior filing. The company confirmed these corrections have no impact on financial performance, profitability, or cash flows. For FY26, the net loss widened to ₹111.18 lakhs from ₹72.65 lakhs YoY. Q4 FY26 net loss was ₹42.05 lakhs versus a ₹17.46 lakh loss YoY. The company received an unmodified opinion from its auditors for the financial year. Total assets stood at ₹171.75 lakhs.
Submission of Revised Audited Financial Results for the Quarter and year Ended 31.03.2026 for Board Meeting held on 19.05.2026
Others (Uncategorized) · 20 May 2026, 12:24 am
Gayatri Bioorganics Resubmits FY26 Results; Net Loss Widens YoY Gayatri Bioorganics resubmitted its audited results for Q4 and FY ended 31 Mar'26 to correct typographical errors, with no impact on financial performance. For FY26, the company's net loss widened to ₹111.18 Lakh from ₹72.65 Lakh YoY, driven by higher finance costs and other expenses. Q4FY26 net loss was ₹42.05 Lakh, an increase from a loss of ₹17.46 Lakh YoY. Negative other equity expanded to ₹(3,700.49) Lakh. The auditor's report noted the financials are prepared on a going concern basis.
Re- Appointment of M/s. Vas & Co., Chartered Accountants as Internal Auditors of the Company for Financial Year 2026-27
Change in Management · 19 May 2026, 11:54 pm
Gayatri Bioorganics Reports FY26 Results, Appoints New Internal Auditors Gayatri Bioorganics' board approved audited results for the quarter and year ended 31 Mar'26. For FY26, the company reported a net loss of ₹111.18 lakhs, a 53% increase from the ₹72.65 lakhs loss in FY25. The Q4FY26 net loss was ₹42.05 lakhs, compared to a loss of ₹17.46 lakhs YoY. Total assets stood at ₹171.75 lakhs. The board also appointed M/s. Vas & Co., Chartered Accountants, as internal auditors for FY 2026-27. The statutory auditor's report contained an unmodified opinion.
Outcome of Board Meeting held on 19.05.2026
Outcome · 19 May 2026, 7:09 pm
Gayatri Bioorganics Limited - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakhs) ■ Revenue: 0.0 ■ EBITDA: -32.3 (-221.5% YoY | -163.3% QoQ) ■ EBITDA Margin (%): 0.0 ■ PAT: -42.1 (-140.8% YoY | -93.7% QoQ) ■ EPS (INR): -0.05 (-150.0% YoY | -66.7% QoQ)
Audited Financial Results along with Audit Report for quarter and year ended 31.03.2026
Financial Result · 19 May 2026, 7:07 pm
Gayatri Bioorganics Limited - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakhs) ■ Revenue: 0.0 ■ EBITDA: -32.3 (-221.5% YoY | -163.3% QoQ) ■ EBITDA Margin (%): 0.0 ■ PAT: -42.1 (-140.8% YoY | -93.7% QoQ) ■ EPS (INR): -0.05 (-150.0% YoY | -66.7% QoQ)
Gayatri Bioorganics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve the Audited financial results ....
Intimation · 19 May 2026, 5:30 am
Gayatri Bioorganics Schedules Board Meeting for Q4 and FY26 Results Gayatri Bioorganics Limited (BSE: 524564) has scheduled a Board of Directors meeting on 19th May'26. The primary agenda is to consider and approve the audited financial results and audit report for the fourth quarter and the full financial year ended 31st Mar'26. The meeting will be held at the company's registered office in Hyderabad.
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Others (Uncategorized) · 01 May 2026, 6:41 pm
Gayatri Bioorganics Confirms It Is Not Classified as a Large Corporate Gayatri Bioorganics Limited (BSE: 524564) has informed the exchange on 01-May-'26 that it does not qualify as a Large Corporate (LC) under SEBI's framework for FY25-26. This classification exempts the company from the mandatory requirement to raise 25% of its incremental borrowings through debt securities. The company reported no mandatory or actual borrowing through debt securities for the period, confirming its non-LC status and thus avoiding associated compliance and potential penalties.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 01 May 2026, 12:19 am
Gayatri Bioorganics Does Not Qualify as a Large Corporate Gayatri Bioorganics Limited, in its disclosure on 30-Apr'26, stated it does not qualify as a "Large Corporate" under SEBI's framework. The company confirmed it only meets the first of three required criteria (having listed securities). It does not meet the thresholds for outstanding long-term borrowings of ₹1,000 crore or more, nor does it possess a credit rating of "AA" or above. Therefore, the mandatory initial disclosure requirement for FY26-27 is not applicable to the company.
Intimation of Postponement of Board Meeting which was scheduled to be held on 15.04.2026
Intimation · 10 Apr 2026, 6:51 pm
Gayatri Bioorganics Postpones Board Meeting on Capital Reduction Gayatri Bioorganics announced the postponement of its Board of Directors meeting, originally scheduled for 15th Apr'26. The meeting was intended to consider a proposal for the reduction of capital. The company cited unavoidable circumstances for the delay. A rescheduled date for the meeting will be communicated to the stock exchange in due course.
Gayatri Bioorganics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/04/2026 ,inter alia, to consider and approve Reduction of capital
Intimation · 15 Apr 2026, 5:30 am
Gayatri Bioorganics Board to Consider Share Capital Reduction Gayatri Bioorganics Ltd (Scrip: 524564) has scheduled a Board Meeting on 15 Apr'26 to consider a Scheme of Reduction of Share Capital. The trading window for insiders has been closed since 01 Apr'26 and will remain so until 48 hours after the declaration of financial results for the quarter and year ended 31 Mar'26. The meeting will address the capital reduction plan and any other matters with the chair's permission, as per Regulation 29 of SEBI Listing Regulations.
Clarification on Price Movement
Others (Uncategorized) · 14 Mar 2026, 3:59 pm
Gayatri BioOrganics Clarifies Share Price Movement Gayatri BioOrganics Limited (Scrip: 524564), in a 14-Mar'26 filing to the BSE, clarified that there are no undisclosed events or price-sensitive information concerning its operations or performance that would justify the recent increase in its share price. The company confirmed compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, stating no extraordinary events have occurred. Management has committed to promptly informing the exchange of any such future developments.
The Exchange has sought clarification from Gayatri BioOrganics Ltd on March 13, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Others (Uncategorized) · 14 Mar 2026, 12:41 am
Outcome of Board meeting held on 10.02.2026
Outcome · 10 Feb 2026, 6:07 pm
Gayatri Bioorganics Reports Widening Net Loss for Q3 FY26 Gayatri Bioorganics reported a net loss of ₹21.71 lakhs for Q3 FY26, ending 31 Dec'25, compared to a loss of ₹16.06 lakhs YoY. The loss also widened from ₹21.13 lakhs in the prior quarter. With zero revenue from operations, total expenses increased to ₹21.71 lakhs from ₹16.06 lakhs YoY, driven by higher employee and finance costs. For the nine months ending 31 Dec'25, the net loss expanded to ₹69.13 lakhs from ₹55.19 lakhs in the previous year. Basic EPS stood at ₹(0.03) for the quarter.
Unaudited quarterly results for quarter ended 31.12.2025
Financial Result · 10 Feb 2026, 6:05 pm
Gayatri Bioorganics Limited - Financial Result for the Quarter ended 31st Dec'25 (Standalone, INR Lakhs) ■ Revenue: 0.0 ■ EBITDA: -12.3 (-43.8% YoY | +2.5% QoQ) ■ EBITDA Margin (%): 0.0 ■ PAT: -21.7 (-35.2% YoY | -2.7% QoQ) ■ EPS (INR): -0.03 (-50.0% YoY | +0.0% QoQ)
Gayatri Bioorganics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve Unaudited financial results ....
Intimation · 10 Feb 2026, 5:30 am
Gayatri Bioorganics Board Meeting on Feb 10, '26 to Approve Q3 Results Gayatri Bioorganics (Scrip: 524564) has scheduled a Board of Directors meeting on 10th Feb'26. The primary agenda is to consider and approve the un-audited financial results for the quarter and nine-month period ended 31st Dec'25. This meeting will determine the company's financial performance for Q3 and the first nine months of the fiscal year.
Board meeting outcome
Financial Result · 14 Nov 2025, 12:03 am
Outcome of Board meeting held on 13.11.2025
Outcome · 14 Nov 2025, 12:00 am